# Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock

> **NCT06404424** · — · COMPLETED · sponsor: **Efferon JSC** · enrollment: 82 (actual)

## Conditions studied

- Sepsis
- Septic Shock

## Interventions

- **DEVICE:** Efferon LPS
- **DEVICE:** Efferon CT

## Key facts

- **NCT ID:** NCT06404424
- **Lead sponsor:** Efferon JSC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2024-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06404424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06404424, "Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06404424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*